S.W. Satola

Dr. S.W. Satola

Emory university school of medicine

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
SSS.W. Satola
S.W. Satola
MFMonica M. Farley
Monica M. Farley
KAKaren F. Anderson
Karen F. Anderson
JPJean B. Patel
Jean B. Patel
Staphylococcus aureus clinical isolates with vancomycin MICs of 2 μg/ml have been associated with vancomycin therapeutic failure and the heteroresistant vancomycin-intermediate S. aureus (hVISA) phenotype. A population analysis profile (PAP) with an area under the curve (AUC) ratio of ≥0.9 for the AUC of the clinical isolate versus the AUC for hVISA strain Mu3 is most often used for determining hVISA, but it is time-consuming and labor-intensive. A collection of 140 MRSA blood isolates with vancomycin MICs of 2 μg/ml by reference broth microdilution and screened for hVISA using PAP-AUC (21/140 [15%] hVISA) were tested by additional methods to detect hVISA. The methods included (i) Etest macromethod using vancomycin and teicoplanin test strips, brain heart infusion (BHI) agar, and a 2.0 McFarland inoculum; (ii) Etest glycopeptide resistance detection (GRD) using vancomycin-teicoplanin double-sided gradient test strips on Mueller-Hinton agar (MHA) with 5% sheep blood and a 0.5 McFarland inoculum; and (iii) BHI screen agar plates containing 4 μg/ml vancomycin and 16 g/liter casein using 0.5 and 2.0 McFarland inocula. Each method was evaluated using PAP-AUC as the reference method. The sensitivity of each method for detecting hVISA was higher when the results were read at 48 h. The Etest macromethod was 57% sensitive and 96% specific, Etest GRD was 57% sensitive and 97% specific, and BHI screen agar was 90% sensitive and 95% specific with a 0.5 McFarland inoculum and 100% sensitive and 68% specific with a 2.0 McFarland inoculum. BHI screen agar with 4 μg/ml vancomycin and casein and a 0.5 McFarland inoculum had the best sensitivity and specificity combination, was easy to perform, and may be useful for clinical detection of hVISA.

1 April 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
SSS.W. Satola
S.W. Satola
FLF. C. Lessa
F. C. Lessa
SRS. M. Ray
S. M. Ray
SBS. N. Bulens
S. N. Bulens
RLR. Lynfield
R. Lynfield
FIfor the Active Bacterial Core surveillance (ABCs) MRSA Investigators
for the Active Bacterial Core surveillance (ABCs) MRSA Investigators
We describe clinical and laboratory characteristics of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections with vancomycin MICs of 2 μg/ml and compare heteroresistant-intermediate S. aureus (hVISA) to non-hVISA. Health care-associated community-onset infections were the most common and resulted in frequent complications and relapses. hVISA-infected patients were more likely to have been hospitalized in the year prior to MRSA culture.

5 March 2024 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PDF file
CLChristina K Lin
Christina K Lin
APAlex Page
Alex Page
SLSarah Lohsen
Sarah Lohsen
AHAli A Haider
Ali A Haider
JWJesse Waggoner
Jesse Waggoner
SSS.W. Satola
S.W. Satola
Heteroresistance (HR), the presence of antibiotic-resistant subpopulations within a primary isogenic population, may be a potentially overlooked contributor to newer β-lactam/β-lactamase inhibitor (BL/BLI) treatment failure in carbapenem-resistant Enterobacterales (CRE) infections. To determine rates of susceptibility and HR to BL/BLIs ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam in clinical CRE isolates. The first CRE isolate per patient per year from two >500 bed academic hospitals from 1 January 2016 to 31 December 2021, were included. Reference broth microdilution (BMD) was used to determine antibiotic susceptibility, and population analysis profiling (PAP) to determine HR. Carbapenemase production (CP) was determined using the Carba NP assay. Among 327 CRE isolates, 46% were Enterobacter cloacae, 38% Klebsiella pneumoniae and 16% Escherichia coli. By BMD, 87% to 98% of CRE were susceptible to the three antibiotics tested. From 2016 to 2021, there were incremental decreases in the rates of susceptibility to each of the three BL/BLIs. HR was detected in each species–antibiotic combination, with the highest rates of HR (26%) found in K. pneumoniae isolates with imipenem/relebactam. HR or resistance to at least one BL/BLI by PAP was found in 24% of CRE isolates and 65% of these had detectable CP. Twenty-four percent of CRE isolates tested were either resistant or heteroresistant (HR) to newer BL/BLIs, with an overall decrease of ∼10% susceptibility over 6 years. While newer BL/BLIs remain active against most CRE, these findings support the need for ongoing antibiotic stewardship and a better understanding of the clinical implications of HR in CRE.

1 June 2012 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
ESEdward Stenehjem
Edward Stenehjem
DRDavid Rimland
David Rimland
ECEmily K. Crispell
Emily K. Crispell
CSCortney Stafford
Cortney Stafford
RGRobert Gaynes
Robert Gaynes
SSS.W. Satola
S.W. Satola
We analyzed the cycle threshold ( C T ) of PCR surveillance MRSA swabs obtained from veterans. Lower C T on admission was associated with a positive culture from nasal swabs at discharge. Compared to PCR, direct plating of nasal swabs performed poorly, especially for patients with an elevated C T . The C T is strongly correlated with quantitative nasal cultures. Clinical and infection control applications of the C T have yet to be defined and warrant further evaluation.

5 March 2024 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PDF file
ABAhmed Babiker
Ahmed Babiker
SLSarah Lohsen
Sarah Lohsen
JRJulia Van Riel
Julia Van Riel
KHKarin Hjort
Karin Hjort
DWDavid S Weiss
David S Weiss
SSS.W. Satola
S.W. Satola
Piperacillin/tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad spectrum of activity that is often used as empirical and/or targeted therapy among hospitalized patients. Heteroresistance (HR) is a form of antibiotic resistance in which a minority population of resistant cells coexists with a majority susceptible population that has been found to be a cause of antibiotic treatment failure in murine models. To determine the prevalence of HR and mechanisms of HR to piperacillin/tazobactam among Klebsiella pneumoniae bloodstream infection (BSI) isolates. From July 2018 to June 2021, K. pneumoniae piperacillin/tazobactam-susceptible BSI isolates were collected from two tertiary hospitals in Atlanta, GA, USA. Only first isolates from each patient per calendar year were included. Population analysis profiling (PAP) and WGS were performed to identify HR and its mechanisms. Among 423 K. pneumoniae BSI isolates collected during the study period, 6% (25/423) were found to be HR with a subpopulation surviving above the breakpoint. WGS of HR isolates grown in the presence of piperacillin/tazobactam at concentrations 8-fold that of the MIC revealed copy number changes of plasmid-located β-lactamase genes blaCTX-M-15, blaSHV33, blaOXA-1 and blaTEM-1 by tandem gene amplification or plasmid copy number increase. Prevalence of HR to piperacillin/tazobactam among bloodstream isolates was substantial. The HR phenotype appears to be caused by tandem amplification of β-lactamase genes found on plasmids or plasmid copy number increase. This raises the possibility of dissemination of HR through horizontal gene transfer and requires further study.

1 August 2009 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
SSS.W. Satola
S.W. Satola
ACAngela M. Caliendo
Angela M. Caliendo
MFMonica M. Farley
Monica M. Farley
JPJean B. Patel
Jean B. Patel
EBEileen M. Burd
Eileen M. Burd